Candel Therapeutics Inc (CADL)
EBITDA Margin
-103519.35%
TTM · Period ending:
CADL EBITDA Margin
Latest reported0.00%period ending
Latest reported0.00%period ending
CADL FY EBITDA Margin (-6738.40% → 0.00%)
Annual ebitda margin
High-resolution chart · PNG
CADL ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| -13,046.4% | |
| -28,713.6% | |
| -10,476% | |
| -6,738.4% |